Webinar
In partnership with Columbia Alumni Association’s Global Health and Wellness Network (GHWN), please join Wilson Sonsini partner Eva Yin for an FDA primer on how medical devices, diagnostics, and pharmaceuticals are regulated, as well as a discussion on general healthcare regulatory considerations and go-to-market strategies for start-ups. The webinar will also feature Chief Business Advisor Matthew Meyer, who will discuss partnering and fundraising best practices for life sciences start-ups.
At the end of the discussion, there will be an engaging Q&A session, allowing the opportunity for guests to ask questions and share their insights. We encourage attendees to come prepared with any questions they may have for our panelists to enhance the conversation.
Columbia Alumni Association’s GHWN is Columbia University’s premier community dedicated to health and wellness. Its mission is to connect and empower Columbia alumni who are passionate about health and wellness by hosting programs that inspire innovation in these fields.
Kaela Japson
kjapson@wsgr.com
Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.
Matthew J. Meyer is chief business advisor for life sciences at Wilson Sonsini Goodrich & Rosati. Based in San Francisco, Matthew leads the firm's life science business advisory practice—a newly formed, innovative resource aimed at providing start-up and emerging life sciences companies with business insights, capabilities, and strategies to help them thrive and address some of their most challenging issues.